Hennion & Walsh Asset Management »

Celldex Therapeutics shares owned by Hennion & Walsh Asset Management

Quarter-by-quarter ownership of Celldex Therapeutics (CLDX) shares owned by Hennion & Walsh Asset Management from 13F filings

Historical chart of Hennion & Walsh Asset Management investment in Celldex Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Celldex Therapeutics held by Hennion & Walsh Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Celldex Therapeutics by Hennion & Walsh Asset Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $926k 36k 25.87
2025-06-30 $428k 21k 20.35

More positions owned by Hennion & Walsh Asset Management

Ishares Tr Core S&p500 Etf (IVV)
Goldman Sachs Etf Tr Activebeta Us Lg (GSLC)
Wisdomtree Tr Dynamic Intl Eqt (DDWM)
Goldman Sachs Etf Tr Activebeta Int (GSIE)
Proshares Tr S&p 500 High Inc (ISPY)
Vanguard Index Fds Value Etf (VTV)
Ishares Tr Investment Grade (IGEB)
Invesco Exchange Traded Fd T S&p500 Eql Wgt (RSP)
NVIDIA Corporation (NVDA)
Broadcom (AVGO)
Columbia Etf Tr Ii Em Core Ex Etf (XCEM)
Ishares Tr Pfd And Incm Sec (PFF)
Pimco Municipal Income Fund II (PML)
Alphabet Cap Stk Cl A (GOOGL)
Nuveen Muni Value Fund (NUV)

View all positions for Hennion & Walsh Asset Management

Top funds holding Celldex Therapeutics

Kynam Capital Management
Wellington Management Company
BlackRock
FMR
Vanguard Group
Point72 Asset Management
Bellevue Group
Commodore Capital
State Street Corporation
Deep Track Capital
Eventide Asset Management
Geode Capital Management
Polar Capital Holdings
Pictet Asset Management Holding SA
Vestal Point Capital

View all funds holding Celldex Therapeutics